Coventry Health Care

Bank of America Merrill Lynch is out with its report today on Coventry Health Care (NYSE: CVH), naming CVH as a "top trade idea." In a note to clients, Bank of America Merrill Lynch writes, "Top 3 reasons why CVH is a top trade idea: 1) Screens well on our analysis, 2) We believe that CVH...

Bank of America reiterated its Buy rating on Coventry Health Care (NYSE: CVH). At the same time, Bank of America raised its price target from $41 to $42. In a research report published today, Bank of America stressed a rate increase in Missouri as a reason for its decision. In the report, Bank of...

Bank of America has raised the price objective on Coventry Health (NYSE: CVH) from $41 to $42 and maintains its Buy rating.

Jefferies is commenting on Coventry Health Care's (NYSE: CVH) 1Q results. “1Q EPS beats by 25%+,” Jefferies writes. “Adjusted EPS of $0.66 (excludes $0.08 impact of MA-FFS discontinuation) was 27% and 31% higher than consensus and JEF estimates, respectively. “Upside driven by MLR and SG&A...

Wedbush Securities has raised the price target on Coventry Health Care (NYSE: CVH) from $32 to $35 and maintains its Neutral rating.

Jefferies has issued a Hold Rating and $33.00 PT for Coventry Health Care (CVH). According to Jefferies, " We are initiating coverage with a Hold rating and a $33 price target. Like many other managed care companies, Coventry has benefitted from low utilization; however, Healthcare Reform poses...

Morgan Stanley published its Morning Equities Summary and made the following changes: Initiating Coverage Health Net (NYSE: HNT) with an Equal-Weight rating. Price Target Changes Up: Buckeye Partners (NYSE: BPL)- Price target from $67 to $68. Copano Energy(NASDAQ: CPNO)- Price target from $31 to $...

Deutsche Bank has issued a report on Managed Care and it's aftermath of the final MLR regulations. In the report, Deutsche Bank writes "Following many months of market anticipation, HHS has now formally certified the minimum MLR model regulation that was proposed by the NAIC. HHS accepted virtually...

Following a solid Q3 showing by Coventry Health Care, Inc. (NYSE: CVH), Morgan Stanley has nudged up its 2011 and 2012 EPS forecasts from $2.45/$2.60 to $2.50/$2.70 (with both still factoring in significant margin pressure). “An 11x multiple on our higher 2012E forecast takes our price target up by...

Following strong 3Q earnings, Goldman Sachs is raising its Coventry Health Care, Inc. (NYSE: CVH) 2010 EPS by $0.77 to $3.65, $0.03 above the high-end of new guidance range of $3.52-$3.62. “We have also modestly raised our 2011-12 EPS, to $2.65 and $2.90 from prior $2.55 and $2.70, but continue to...

Deutsche Bank has issued an industry alert report on the Managed Care sector rate filings published by Blue Cross Blue Shield of North Carolina (BCBS-NC). This report was submitted by BCBS-NC to the NC Department of Insurance for plan effective January 1, 2011, when some of the initial health care...

J.P. Morgan has released a research report on Coventry Health Care, Inc (NYSE: CVH) and has reiterated its ‘neutral’ rating on the stock and price target of $26. According to an analyst at J.P. Morgan, shares of Coventry are currently being traded at 8.1x and 7.4x with 2011 and 2012 earnings...